Drug Profile
Lamotrigine controlled-release
Alternative Names: Lamictal XR; Lamotrigine CR; Lamotrigine ER; Lamotrigine extended-releaseLatest Information Update: 16 Aug 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antidepressants; Antiepileptic drugs; Chlorobenzenes; Mood stabilisers; Small molecules; Triazines
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Partial epilepsies; Tonic-clonic epilepsy